---
date:
  created: 2024-08-09T16:05:45
  updated: 2025-05-22T13:15:32
  finished: 2025-05-22T13:15:33
tags:
  - share
  - medicine/CNS
share: true
categories:
  - medicine
alias: cns
status: finished
---
# CNS Infection  
source:: Pocket Medicine, 2022  
  
<!-- more -->  
## ACUTE BACTERIAL MENINGITIS  
  
### Definition  
  
- Inflammation of tissue around the brain/spinal cord  
- Usually arising from nasopharynx (hematogenous spread), bacteremia, or direct inoculation (surgery, contiguous infection, trauma, foreign body [eg, CSF shunt])  
  
#### **Microbiology in Bacterial Meningitis** (_NEJM_ 2011;364:2016)  
  
| Pathogen                   |                                                                                                                                                                                                                            |  
| -------------------------- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |  
| _S. pneumoniae_ (30-60%)   | Look for preceding infection (bacteremia, pneumonia, endocarditis)<br><br>Drug-resistant _S. pneumoniae:_<br>  ˜40% PCN-resistant (even _intermediate_ resistance problematic)<br>  ˜<10% 3rd-gen. cephalosporin-resistant |  
| _N. meningitidis_ (10-35%) | Primarily in age <30 y; associated petechiae or purpura<br><br>↑ risk in asplenia, complement defic., HIV, SCT, unvaccinated<br><br>Vaccine rec for all age 11-18 y, HIV infection, asplenia, C5-9 deficiency              |  
| _H. influenzae_ (<5%)      | ↑ risk in asplenia, complement defic., HIV, SCT, unvaccinated, CSF leak, trauma/surgery, mastoiditis<br><br>Vaccine rec for all children; markedly ↓ incidence                                                             |  
| _L. monocytogenes_ (5-10%) | ↑ in immunosupp (glucocorticoids, transplant), elderly, malignancy, pregnant, cirrhosis. Outbreaks a/w contaminated dairy & raw veg.                                                                                       |  
| GNBs (1-10%)               | More common in health care associated meningitis (_E. coli, Klebsiella sp., Pseudomonas aeruginosa)_                                                                                                                       |  
| _Staphylococci_ (5%)       | Preceding infection (endocarditis, bacteremia), post CNS surgery, foreign bodies (CSF) shunt, intrathecal pump)                                                                                                            |  
| Mixed infection            | Suspect parameningeal focus or CSF leak, post CNS surgery                                                                                                                                                                  |  
### Clinical manifestations (Lancet 2016;339:16)  
- Headache (84%), fever (74%), stiff neck (74%), photosensitivity, GCS <14 (71%), nausea (62%), seizure (23%); 95% have 2 of 4: HA, fever, stiff neck, ΔMS  
- Presentation may be atypical (eg, lethargy w/o fever) in elderly and immunosupp.  
  
### Physical exam (CID 2002;35:46; Am J Emerg Med 2013;31:1601)  
- Nuchal rigidity (Se 30%, Sp 68%), Kernig's sign (Se 5%, Sp 95%), Brudzinski's sign (Se 5%, Sp 95%), jolt sign (HA worsens w/ horizontal rotation) (Se 64%, Sp 43%)  
- ± Focal neuro findings (˜30%; hemiparesis, aphasia, visual field cuts, CN palsies)  
- ± HEENT findings: sinus tenderness, clear rhinorrhea (CSF leak)  
- ± Skin and joint findings: petechial rash (N. meningitidis), genital or oral ulcers (HSV), arthritis with joint effusion (N. meningitidis)  
  
### Sequential management of bacterial meningitis  
- Blood cx, initiate empiric antibiotics, consider corticosteroids (vide infra)  
- CT head if indicated (see below)  
- LP ASAP (if not contraindicated); yield of CSF cx unlikely to be changed if obtained w/in ˜4 h of initiation of abx  
  
### Diagnostic studies (NEJM 2017;388:3036)  
- Blood cultures ×2 before abx  
- WBC count: >10,000 in >90% of bacterial meningitis in healthy hosts  
- Head CT to r/o mass effect before LP if ≥1 high-risk feature: immunosupp., h/o CNS disease, new-onset seizure, focal neuro findings, papilledema, GCS <15 (CID 2004;39:1267)  
- Lumbar puncture with opening pressure (NEJM 2006;355:e12)  
- Send CSF for cell count and differential, glucose, protein, Gram stain, bacterial cx  
- Additional CSF studies based on clinical suspicion: AFB smear/cx (or MTb PCR), cryptococcal Ag, fungal cx, VDRL, PCR (HSV, VZV, enteroviral), cytology  
- CSF Gram stain has 30-90% Se; cx 80-90% Se if LP done prior to abx though abx should not be delayed for LP if there is concern for bacterial meningitis  
- Rule of 2s: **CSF WBC >2k, gluc <20, TP >200** has >98% Sp for bacterial meningitis  
- Repeat LP only if no clinical response after 48 h of appropriate abx or CSF shunt  
- Metagenomic next-generation sequencing ↑ dx yield (NEJM 2019;380:2327)  
  
#### Typical CSF Findings in Meningitis  
  
| **Type**      | **Appearance** | **Pressure (cm H2O)** | **WBC/mm3 *Predom Type*** | **Glc (mg/dL)** | **TP (mg/dL)** |  
| ------------- | -------------- | --------------------- | ------------------------- | --------------- | -------------- |  
| **Normal**    | Clear          | 9-18                  | 0-5 _lymphs_              | 50-75           | 15-40          |  
| **Bacterial** | Cloudy         | 18-30                 | 100-10,000 _polys_        | <45             | 100-1000       |  
| **TB**        | Cloudy         | 18-30                 | <500 _lymphs_             | <45             | 100-200        |  
| **Fungal**    | Cloudy         | 18-30                 | <300 _lymphs_             | <45             | 40-300         |  
| **Aseptic**   | Clear          | 9-18                  | <300 _polys_ → _lymphs_   | 50-100          | 50-100         |  
### Empiric Treatment of Bacterial Meningitis (_Lancet_ 2012;380:1693)  
  
| **Adults <50 y**                                         | Ceftriaxone + vancomycin (trough 15-20), consider acyclovir IV                                             |  
| -------------------------------------------------------- | ---------------------------------------------------------------------------------------------------------- |  
| **Adults >50 y**                                         | Ceftriaxone + vancomycin + ampicillin, consider acyclovir IV                                               |  
| **Immunosuppressed**                                     | [Cefepime _or_ meropenem] + vanc ± amp (not nec. if on meropenem), consider acyclovir IV & fungal coverage |  
| **Healthcare assoc. infection (eg, surgery, CSF shunt)** | [Cefepime _or_ meropenem _or_ ceftazidime] + vancomycin                                                    |  
- When possible, organism-directed Rx, guided by sensitivities or local patterns of drug resistance should be used  
- Confirm appropriate dosing as higher doses are often needed in meningitis (though may need to be adjusted for renal function)  
- **Corticosteroids**: If causative organism is unknown, dexamethasone 10 mg IV q6h × 4 d recommended prior to or with initiation of abx. Greatest benefit in ***S. pneumoniae* and GCS 8-11** (↓ neuro disability & mortality by ˜50%). ==Avoid in crypto== (NEJM 2016;374:542).  
- Prophylaxis: for close contacts of Ptw/N. meningitidis; rifampin (600 mg PO bid × 2 d) or ciprofloxacin (500 mg PO × 1) or ceftriaxone (250 mg IM × 1).  
- Precautions: droplet precautions until N. meningitidis is ruled out  
  
## ASEPTIC MENINGITIS  
  
### Definition  
  
- Clinical/lab evidence of meningeal inflammation with negative bacterial cx (CSF & blood)  
  
### Etiologies (Neurology 2006;66:75)  
  
- Viral: enteroviruses are most common cause (summer/fall; rash, GI, URI sx), HIV, HSV, VZV, mumps (parotitis), lymphocytic choriomeningitis virus (rodent exposure), encephalitis viruses, adenovirus, polio, CMV, EBV, WNV  
- Focal bacterial infection: brain/epidural/subdural abscess, CNS septic thrombophlebitis  
- Partially treated bacterial meningitis  
- Other infectious: TB, fungal (cryptococcus, coccidiodes), Lyme, syphilis, leptospirosis  
- Neoplasm: intracranial tumors (or cysts), lymphomatous or carcinomatous meningitis  
- Drug-induced meningitis: NSAIDs, IVIG, antibiotics (TMP-SMX, PCN), anti-epileptics  
- Systemic autoimmune illness: SLE, sarcoidosis, Behçet's, Sjögren's syndrome, RA  
- Mollaret's: recurrent lymphocytic meningitis, spontaneously resolving (often HSV-2)  
  
### Diagnosis  
  
- Obtain LP for CSF analysis: lymphocytic pleocytosis common in viral etiologies (see Typical CSF Findings in Meningitis table above)  
- Consider CSF cytology and MRI brain/spine to evaluate for malignancy  
- Consider serum autoimmune and serum viral testing in appropriate settings if CSF is unrevealing and there is no improvement with empiric treatment  
  
### Empiric treatment  
  
- Suspected bacterial meningitis: see empiric treatment of bacterial meningitis above  
- Suspected viral meningitis: if concern for HSV meningoencephalitis → IV acyclovir  
- Unclear etiology: consider initiation of empiric bacterial meningitis treatment while observing and awaiting CSF studies  
  
## ENCEPHALITIS (NEJM 2018;379:557)  
  
### Definition  
  
- Inflammation of brain parenchyma characterized by impaired cerebral function (AMS, neurologic deficits) often due to primary viral infection or post-viral inflammation  
  
### Etiologies (specific etiology found in <20% of cases; Neurology 2006;66:75; CID 2008;47:303)  
  
- HSV-1 all ages/seasons. If sxs recur after Rx, consider viral relapse vs. autoimmune encephalitis b/c high rates of autoimmune disease wks later (Lancet Neurol 2018;17:760)  
- VZV 1° or reactivation; ± vesicular rash; all ages (favors elderly), all seasons  
- Arboviruses: evaluate for exposure to vector/geography. Mosquitoes: West Nile, Eastern/Western equine, St. Louis, La Crosse; Ixodes tick: Powassan.  
- Enteroviruses (coxsackie, echo): preceding URI/ GI sx; peaks in late summer/early fall  
- Other infectious: CMV, EBV, HIV, JC, measles, mumps, rabies, adeno, influenza, Lyme  
- Non-infectious: autoimmune/paraneoplastic (anti-NMDAR, anti-Hu, anti-Ma2, anti-CRMP5, anti-mGluR5), post-infxn demyelination (eg, ADEM)  
  
### Clinical manifestations  
  
- Fever + ΔMS (subtle to severe), seizure, focal neuro deficit, HA in meningoencephalitis  
  
### Diagnostic studies (CID 2013;57:1114)  
  
- CSF analysis: lymphocytic pleocytosis; PCR for HSV (95% Se & Sp), VZV; consider other PCR based on risk factors (CMV/EBV, HIV, JC, adeno/enterovirus, WNV)  
- Consider testing for autoimmune etiologies and serologic viral testing in appropriate settings if CSF is unrevealing and there is no improvement with empiric HSV/VZV Rx  
- MRI (CT if unavailable); HSV temporal lobe; W. Nile & Powassan thalamic hyperintensity  
- EEG to r/o seizure; findings in encephalitis are nonspecific (temporal lobe focus in HSV)  
  
### Treatment  
  
- HSV/VZV: IV acyclovir 10 mg/kg IV q8h; consider empiric treatment given frequency  
  
## BELL'S PALSY  
  
### Definition & clinical manifestations  
  
- Acute idiopathic unilat. facial nerve palsy (CN VII), often presumed HSV reactivation  
- P/w unilateral facial muscle weakness, hyperacusis, ↓ taste, lacrimation, & salivation  
- Risk factors: pregnancy (preeclampsia), obesity, HTN, diabetes, preceding URI  
  
### Diagnosis (Otol Head Neck Surg 2013;149:656)  
  
- Labs, imaging, EMG not needed in routine cases  
- Ddx: Bilateral: Lyme, GBS, sarcoid. Additional neuro sx: stroke, tumor. Rash: herpes zoster. Other: otitis media, HIV, Sjögren.  
  
### Treatment and Prognosis (CMAJ 2014;186:917)  
  
- 70% recover spontaneously w/in 6 mos, >80% recover with glucocorticoid treatment  
- Oral corticosteroids started w/in 72 hrs of sx onset improve odds of recovery; dose varies based on severity (House-Brackmann grading). No conclusive data on antivirals.  
- If eyelid closure is compromised, eye protection is crucial to prevent trauma  
  
## HERPES ZOSTER (SHINGLES)  
  
### Definition & etiology  
  
- Painful vesicular rash in a peripheral nerve distribution due to reactivation of VZV  
- Spread by contact with active lesion (prior to crusting) in uncomplicated zoster or via airborne transmission in disseminated zoster  
  
### Clinical manifestations & complications  
  
- Uncomplicated: pain in a dermatomal distribution → dermatomal eruption of erythematous papules → vesicles → crusted plaques in varying stages of evolution  
- Disseminated: vesicles across multiple dermatomes, visceral organ involvement (pneumonia, hepatitis, CNS) seen in immunosupp. (eg, transplant, malignancy)  
- Zoster opthalmicus: ocular involvement (V1 of CN V) requires urgent ophtho eval  
- Post-herpetic neuralgia: neuropathic pain lasting >90 d after dx  
  
### Diagnosis  
  
- Clinical diagnosis if uncomplicated  
- Confirm with PCR (most sensitive), DFA, and viral culture (allows for resistance testing) of vesicular fluid (scrape from unroofed vesicle)  
  
### Treatment & prevention  
  
- Uncomplicated: acyclovir, valacyclovir, or famciclovir x 7 d; initiate w/in 72 h of onset for greatest benefit; consider after 72 h if new lesions present; minimal benefit after crusting  
- Superimposed bacterial cellulitis is common; if suspected, treat with appropriate antibiotics  
- Disseminated/immunosupp.: IV acyclovir, eval for visceral spread, droplet precautions  
- Prevention: Shingrix (2 doses) for all Pts >50; consider in younger if immunosupp.